A study to assess the relative bioavailability of 3 different formulations under fasted and fed condition

Trial Identifier:	D5495C00005
Sponsor:	AstraZeneca
NCTID::	NCT04024501
Start Date:	July 2019
Primary Completion Date:	September 2019
Study Completion Date:	September 2019
Condition:	Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	German Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Berlin, Germany, 14050

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.